Ctrl

K

Nirmatrelvir / ritonavir

Class
Antiviral agents
Subclass
Protease inhibitors
Substance name
Nirmatrelvir / ritonavir
Brand names
Paxlovid®
Contains
Nirmatrelvir
Ritonavir
Common formulations
Tablet blister pack
Dosage and administration
Adults patients
Treatment of COVID-19 infection • Mild-to-moderate, outpatient setting
•
300/100 mg PO BID for 5 days
Indications for use
Labeled indications
Adults
•
Treatment of COVID-19 infection (mild-to-moderate, outpatient setting)
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource